Table 2 Socio-demographic and clinical data of asymptomatic cases starting from 2011 until end of June 2017
2011 n(%) | 2012 n(%) | 2013 n(%) | 2014 n(%) | 2015 n(%) | 2016 n(%) | S1 2017 n(%) | TOTAL | |
|---|---|---|---|---|---|---|---|---|
Number of asymptomatic LGV cases | 0 | 1 | 3 | 0 | 4 | 9 | 6 | 23 |
Gender | 23/23 known | |||||||
Male or Trans female | 0 | 1 | 3 | 0 | 3 | 9 | 6 | 22 (96%) |
Female | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 1 (4%) |
Transmission of all men | 22/22 knowna | |||||||
MSM | 0 | 1 | 3 | 0 | 3 | 9 | 6 | 22 (100%) |
HETERO | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 (0%) |
Age scale | 22/22 knowna | |||||||
31–40 | 0 | 1 | 1 | 0 | 0 | 4 | 3 | 9 (41%) |
41–50 | 0 | 0 | 2 | 0 | 1 | 4 | 3 | 10 (45%) |
51–60 | 0 | 0 | 0 | 0 | 2 | 1 | 0 | 3 (14%) |
Geographical location in Belgium | 22/22 knowna | |||||||
Living in Flemish region | 0 | 1 | 2 | 0 | 3 | 7 | 5 | 18 (82%) |
Living in French region | 0 | 0 | 1 | 0 | 0 | 1 | 1 | 3 (14%) |
Living in the capital region | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 1 (4%) |
Kind of Sample | 22/22 knowna | |||||||
Anorectal | 0 | 1 | 3 | 0 | 3 | 8 | 6 | 21 (95%) |
Urine | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 1 (5%) |
HIV Status | 22/22 knowna | |||||||
Positive | 0 | 1 | 3 | 0 | 2 | 5 | 3 | 14 (64%) |
Negative | 0 | 0 | 0 | 0 | 1 | 4 | 3 | 8 (36%) |
Co-infections other than HIV | 21/22 knowna | |||||||
None | 0 | 0 | 0 | 0 | 2 | 1 | 2 | 5 (24%) |
Only one | 0 | 0 | 2 | 0 | 1 | 5 | 2 | 10 (48%) |
Two or more | 0 | 1 | 1 | 0 | 0 | 3 | 1 | 6 (29%) |
Gonorrhea | 0 | 1 | 2 | 0 | 0 | 6 | 1 | 10 (48%) |
Syphilis | 0 | 1 | 2 | 0 | 0 | 2 | 1 | 6 (29%) |
Chlamydia A-K | 0 | 0 | 0 | 0 | 1 | 0 | 1 | 2 (10%) |
Hepatitis B | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 1 (5%) |
Mycoplasma genitalium | 0 | 0 | 0 | 0 | 0 | 2 | 1 | 3 (14%) |